Urinary lithiasis (part I). Non-metabolic factors associated with urolithiasis Article published in Urologia Polska 2005/58/3.
authors
-
Bożena Eberdt-Gołąbek
- Instytut Matki i Dziecka w Warszawie, Klinika Pediatrii
Dyrektor instytutu: prof. dr hab. Wojciech Woźniak
Kierownik kliniki: prof. dr hab. Andrzej Milanowski
keywords
-
urinary tract, urinary lithiasis, non-metabolic forms of urinary lithiasis
summary
- Introduction.
- Urinary lithiasis is not always an isolated finding, which is treated by surgical procedures. Frequently, there is a severe inborn metabolic disorder of various etiology responsible for the progressive stone formation. Hence the diagnosis of the different etiological factors makes prophylaxis easier.
- The aim of the study.
- The aim of this presentation is to demonstrate the pathomechanism of renal stone formation and to discuss the non-metabolic factors which are involved, such as: infectious urinary lithiasis, idiopathic oxalic urinary lithiasis, distal ileal dysfunction, after resection of ileum terminale, in cases of renal pyramid spongiosis and after long-term immobilisation.
- Conclusions.
- Each patient with urolithiasis should undergo investigations in order to establish the etiology. Non-metabolic etiology of urinary lithiasis is not the most common cause of renal stone formation.
references
- Miliner DS: Urolithiasis in pediatric patients. Mayo Clinic. Proceed 1993; 68; 241-248.
- Iguchi M et al: Prevalance of urolithiasis in Kaizuka city, Japanan epidemiologic study urinary stones. Int J Urol 1996; 3; 175-179.
- Daszkiewicz E, Wyszyńska T: Kamica układu moczowego, w: Choroby układu moczowego u dzieci. T. Wyszyńska (red.), PZWL, 1975, 148-152
- Eberdt-Gołąbek B: Badania nad przyczynami metabolicznymi kamicy układu moczowego. Praca doktorska, 1979.
- Gołąbek B, Słowik M, Jaros I, Drejewicz H, Makowska U: 25-letnie doświadczenie w zakresie profilaktyki nawrotowej kamicy układu moczowego u dzieci. Urol Pol 2004; 57; 82-89.
- Bass HN, Emarel B: Nephrolithiasis in children. J Urol 1966; 95; 749-553.
- Malek RS, Kolodis PP: Pediatric nephrolithiasis. J Urol 1975; 118; 897-899.
- Fleisch H: Inhibitors and promoteres of stone formation. Kidney Int 1978; 13; 361-371.
- Marangella M, Bagnis C: Crystallization inhibitors in the pathophysiology and treatment of nephrolithiasis. Urol Int 2004; 72 Suppl 1; 6-10.
- Finlayston MD: Renal lithasis in reviev. Symposium of renal lithiasis. Urol Clin North Am 1974; 1; 181-212.
- Pak CYC: Physiochemical basis for the formation of renal stones of calcium phosphate origin: calculation of the degree of saturation of urine with respect to brushite. J Clin Invest 1969; 48; 1914-1922.
- Robertson WG, Peacock M: Calcium oxalate cristaluria and urine saturation in recurrent renal stone formers. Clin Sci 1971; 40; 365-374.
- Pak CYC, Watres O et al: Mechanism for calcium urolithiasis among patiens with hyperuricosuria: Supersaturation of urine with respect to monosodium urate. J Clin Invest 1977; 59; 426-431.
- Walinder O, Ljunghall S, Wibell L et al: Urinary excretion of cyclic AMP in hyperparathyroidism. Scand. J Urol Nephrol 1978; 12; 67-71.
- Pak CYC, Holt K: Nucleation and growth of brushite and calcium oxalate in urine of stone formes. Metabolism 1976; 25; 665-673.
- Asplin JR, Parks JH, Nakagawa Y, Coe FL: Reduced crystallization inhibition by urine from women with nephrolithiasis. Kidney Int 2002; 61; 1821-1829.
- Langley SEM, Fry CH: Differences in the free Ca2+ in undiluted urine from stone formers and normal subjects using a new generation ofionselective electrodes. Br J Urol 1995; 75; 288-295.
- Langley SEM, Fry CH: The influence of pH on urinary ionized (Ca2+) differences between urinary tract stone formers and normal subjects. Br J Urol 1997; 79; 8-14.
- Coe FL, Lawton RL: Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc Soc Exp Biol Med 1975; 149; 926-929.
- Lerolle N, Lantz B, Paillard F et al: Risk factors for nephrolithiasis in patients with familial idiopathic hypercalciuria. Am J Med 2002; 113; 99-103.
- Meyer JL, Bergert JH, Smith LH et al: Epitaxial relationships in urolithiasis: the calcium oxalate monohydrate hydroxyapatite system. Clin Sci Mol Med 1975; 49; 369-371.
- Muldowney FP: Diagnostic approach to hypercalciuria. Kidney Int 1979; 16; 637-648.
- Coe FL, Strauss AL, Tembe V et al: Uric acid saturation in calcium nephrolithiasis. Kidney Int 1980; 17; 661-668.
- Barilla DE, Toletino R et al: Selective effects of thiazide on intestinal absorption of calcium in absorptive and renal hypercalciurias. Metabolism 1978; 27; 125-131.
- Yendt ER: Renal calculi. Canad Med Assoc J 1970; 102; 479-489.
- McCarron DA, Rankin LJ, Bennett WM et al: Urinary calcium excretion of extremes of sodium intake in normal man. Am J Nephrol 1981; 1; 84-90.
- Muldowney FP, Freaney R, Moloney MF: Importance of dietary sodium in the hypercalciuria syndrom. Kidney Int 1982; 22; 292-296.
- Meschi T, Schianchi T, Ridolo E et al: Body weight, diet and water intake in preventing stone disease. Urol Int 2004; 72 Suppl 1: 29-33.
- Ferrari L, Meschi M et al: Etiopathogenesis and clinical aspects of nephrolithiasis-at present. Recenti Prog Med 2003; 94; 136-141.
- Moyad MA: Calcium oxalate kidney stones: another reason to encourage moderate calcium intakes and other dietary changes. Urol Nurs 2003; 23; 310-313.
- Kaplan RA, Pak CYC: Diagnosis and managment of renal calcul. Tex Med 1974; 70; 88-93.
- Melick RA, Henneman PH: Clinical and laboratory studies of 207 consecutive patients in the kidney stone. N Engl J Med 1958; 259; 307-314.
- Penido MG, Diniz JS et al: Idiopathic hypercalciuria: presentation of 471 cases. J Pediatr 2001; 77; 101-104.
- Massey LK: Effects of ascorbate supplements on urinary oxalate and risk of kidney stones. J Am Diet Assoc 2000; 100; 516-519.
- Traxer O, Huet B, Poindexter J et al: Effect of ascorbic acid cosnumtions of pes ofurinary stone risk factors. J Urol 2003; 170; 397-401.
- Wandzilak TR, D?Andre SD, Davis PA et al: Effect of high dose vitamin C on urinary oxalate levels. J Urol 1996; 151; 834-837.
- Schwille PO, Schmiedl A, Herrmann U et al: Ascorbic acid in idiopathic recurrent calcium urolithiasis in humans-does it have an abettor role in oxalate, and calcium oxalate crystalization? Urol Res 2000; 28; 167-177.
- Williams HE, Smith LH: Disorders of oxalate metabolism. Am J Med 1968; 45; 715-735.
- O?Connor RC, Worcester EM, Evan AP et al: Nephrolithiasis and nephrocalcinosis in rats with small bowel resection. Urol Res 2005; 33 (2); 105-115
- Ghazali S, Barratt TM: Urinary excretion of calcium and magnesium in children. Arch Dis Child 1974; 49; 97-101.
- Oreopoulos DG, Sayannwo MA: Magnesium/calcium ratio in urine of patents of renal stone. Lancet 1968; 2; 420-422.
- Takasaki E: The magnesium/calcium ratio in the concentrated urines of patients with calcium oxalate calculi. Ivest Urol 1972; 10; 147-150.
- Chodwick VS, Madna K et al: Mechanism for hyperoxaluria in patients with ileal dysfunction. N Eng J Med 1973; 289; 172-176.
- Trinchieri A, Lizzano R, Castelnuovo et al: Urinary patterns of patients with renal stones associated with chronic inflammatory bowel disease. Arch Ital Urol Androl 2002; 74; 61-64.
- Griffith DP, Musher DM: Urease the primary cause of infection induced urinary stones. Invest Urol 1976; 13; 346-350.
- Gleeson MJ, Griffith DP: Struvite calculi. Br J Urol 1993; 71; 503-511.
correspondence
Bożena Eberdt-Gołąbek
Klinika Pediatrii
ul. Kasprzaka 17a
01-211 Warszawa
tel. /fax (022) 32 77 043
pediatria@imid.med.pl
|